ACC 2008: Spirit II results back Abbott's Xience V over Taxus, but Boston Scientific still happy
This article was originally published in Clinica
Executive Summary
Xience V, the drug-eluting stent (DES) developed by Abbott, has beaten Boston Scientific's Taxus device in a head-to-head trial.